CHPA applauds the House of Representatives’ passage of legislation that will restore consumers’ ability to use their HSAs and FSAs to purchase over-the-counter medicines and feminine hygiene products.
CHPA is pleased to see FDA’s long-awaited draft guidance on innovative approaches for greater consumer access to nonprescription medicines, and applauds FDA’s focus on patient safety as a top priority.
CHPA is pleased to see FDA’s long-awaited draft guidance on innovative approaches for greater consumer access to nonprescription medicines, and applauds FDA’s focus on patient safety as a top priority.
Herein, CHPA provides feedback on the Agricultural Marketing Service (AMS) request for comments on a Proposed Rule to establish the national mandatory bioengineered food disclosure standard.
CHPA applauds New Hampshire for becoming the 35th state to adopt the real-time, stop-sale technology called the National Precursor Log Exchange (NPLEx), a system used by retailers across the country to help prevent the illegal sale of pseudoephedrine.
Restricting consumers’ ability to utilize their own FSAs and HSAs and other tax-preferred accounts impose an unfair cost increase on individuals and families at a time when many are struggling financially.
The CHPA Educational Foundation today released findings from a study examining the common attitudes and behaviors of parents when administering pediatric over-the-counter (OTC) liquid medicines to young children.
